Abstract
Background: Severe Acute Respiratory Syndrome Coronavirus 2 has affected millions of people, and especially in adult patients with underlying diseases lead to death. Meanwhile pediatric patients with inherited defects of T cell should be prone to viral diseases.
Case Presentation: Herein, we report an infant with severe combined immunodeficiencies, who were affected and died because of COVID-19.
Conclusion: Considering the importance of finding how immune system can affect the viral infection, presentation of COVID-19 in immune deficient patients can be valuable.
Keywords: Combined immunodeficiency, COVID-19, cardiac injury, infant, death, bone marroow.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Death Due to COVID-19 in an Infant with Combined Immunodeficiencies
Volume: 21 Issue: 9
Author(s): Hamid Ahanchian, Nasrin Moazzen*, Amin Saeidinia, Seyed H. Joghatayi, Maryam Khoshkhui, Mohammad H. Aelami, Nasrin S. M. Haghi and Nima Rezaei*
Affiliation:
- Allergy Research Center, Mashhad University of Medical Sciences, Mashhad,Iran
- Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran,Iran
Keywords: Combined immunodeficiency, COVID-19, cardiac injury, infant, death, bone marroow.
Abstract:
Background: Severe Acute Respiratory Syndrome Coronavirus 2 has affected millions of people, and especially in adult patients with underlying diseases lead to death. Meanwhile pediatric patients with inherited defects of T cell should be prone to viral diseases.
Case Presentation: Herein, we report an infant with severe combined immunodeficiencies, who were affected and died because of COVID-19.
Conclusion: Considering the importance of finding how immune system can affect the viral infection, presentation of COVID-19 in immune deficient patients can be valuable.
Export Options
About this article
Cite this article as:
Ahanchian Hamid , Moazzen Nasrin *, Saeidinia Amin , Joghatayi H. Seyed , Khoshkhui Maryam , Aelami H. Mohammad , Haghi S. M. Nasrin and Rezaei Nima *, Death Due to COVID-19 in an Infant with Combined Immunodeficiencies, Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21 (9) . https://dx.doi.org/10.2174/1871530320666201021142313
DOI https://dx.doi.org/10.2174/1871530320666201021142313 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Contribution of MEK1/ERK1/2/iNOS Pathway to Oxidative Stress and Decreased Caspase-3 Activity in Endotoxemic Rats
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Hyperhomocysteinemia in Movement Disorders: Current Evidence and Hypotheses
Current Vascular Pharmacology The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil
Current Respiratory Medicine Reviews Analytic strategies to evaluate the association of time-varying exposures to HIV-related outcomes: Alcohol consumption as an example
Current HIV Research Targeted Therapy for Brain Tumours: Role of PARP Inhibitors
Current Cancer Drug Targets Recent Advancements in Pharmacological Stent Therapy Using Polymeric Materials: Opportunities and Challenges
Current Drug Delivery Antisense Technology: A Selective Tool for Gene Expression Regulation and Gene Targeting
Current Pharmaceutical Biotechnology Aspergillus – Classification and Antifungal Susceptibilities
Current Pharmaceutical Design Chalcones as Versatile Synthons for the Synthesis of 5- and 6-membered Nitrogen Heterocycles
Current Organic Chemistry Obesity: Current Treatment and Future Horizons
Mini-Reviews in Medicinal Chemistry The Significance of Oxidized Low-Density Lipoprotein in Body Fluids as a Marker Related to Diseased Conditions
Current Medicinal Chemistry Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Metabolomics Approach Reveals Altered Plasma Amino Acid and Sphingolipid Profiles Associated with Patholological State in Transition Dairy Cows
Current Metabolomics Organophosphorus Compounds: Intervention in Mechanisms of Signal Transduction Relevant to Proliferative, Immunological and Circulatory Disorders
Current Medicinal Chemistry Recent Development in Identification of Potential Novel Therapeutic Targets Against Trypanosomatids
Current Topics in Medicinal Chemistry Toxicity of Carbon Nanotubes
Current Drug Metabolism Determinants of Longevity: Genetics, Biomarkers and Therapeutic Approaches
Current Pharmaceutical Design Advances in Helper-Dependent Adenoviral Vector Research
Current Gene Therapy Fullerenes: From Carbon to Nanomedicine
Mini-Reviews in Medicinal Chemistry Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restenosis and Inflammatory Diseases
Current Pharmaceutical Design